Connect with us

Hi, what are you looking for?

Tuesday, May 30, 2023
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Avextra imports medical cannabis extracts to Italy

Italy has the second largest patient population for medical cannabis in the European Union

Avextra imports medical cannabis extract to Italy
Image via Avextra

Germany’s Avextra AG, a medical cannabis company partly owned by Seed Innovations Ltd (LON: SEED), has expanded its European footprint by shipping EU-GMP certified cannabis extracts to Italy.

Avextra announced the accomplishment on Wednesday and says it is one of only three companies permitted to import medical cannabis products into the country.

The company also says that Italy has the second largest patient population for medical cannabis products in the European Union and that 70 per cent of that market is allocated to extracts like the ones Avextra has now imported.

“We have had extensive discussions with Italian doctors and pharmacies and see a clear need for standardized extracts in Italy,” said Avextra’s Co-CEO Bernhard Babel.

“Our Italian team have regularly participated in scientific conferences and built relationships with leading researchers and clinicians and see strong potential for medical cannabis therapies to grow and develop in Italy.”

Read more: Clever Leaves gets Brazilian GMP cannabis certification

Read more: Switzerland approves more adult-use cannabis pilot projects

Avextra announced on Monday that it had raised £17 million to help expand its business from a series of private investors.

In February, the company began exporting its extracts into the United Kingdom where it currently holds an ownership stake in a series of medical cannabis dispensaries owned by Integro Medical Clinics.

Avextra owns a substantial cannabis cultivation facility in Portugal in addition to the German facility where the extracts were produced. The company was formerly known as the Eurox Group before rebranding itself as Avextra last fall.

Seed says that as of September 30 last year it owned a 6.6 per cent stake in Avextra on a fully diluted basis valued at approximately £4.4 million.

Seed’s shares are currently worth the equivalent of $0.03 on the London Stock Exchange, dropping by 0.79 per cent Wednesday.


Follow Mugglehead on Twitter

Follow Rowan Dunne on Twitter




Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


The company will be supporting the cancer and patient care conference ONCOWELLNESS


The company received its fifth GMP certification from the European Union, Colombia and Brazil


The company will be supplying Germany's Sanity Group with high-grade medical cannabis flower


The company aims to start selling TGOD products starting in in Q4 this year